CIRRX | NREEX | CIRRX / NREEX | |
Total Expense Ratio | 1.25 | 0.08 | 1,563% |
Annual Report Gross Expense Ratio | 1.25 | 0.88 | 142% |
Fund Existence | 11 years | 3 years | - |
Gain YTD | 4.051 | 0.670 | 605% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.03B | 690M | 1,163% |
Annual Yield % from dividends | 1.82 | 2.92 | 62% |
Returns for 1 year | 11.00 | 11.31 | 97% |
Returns for 3 years | 15.04 | 4.74 | 317% |
Returns for 5 years | 32.42 | N/A | - |
Returns for 10 years | 35.42 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RIRCX | 74.94 | 0.04 | +0.05% |
American Funds Capital Income Bldr R3 | |||
DVLCX | 22.44 | N/A | N/A |
BNY Mellon Opportunistic Midcap Value C | |||
CTCAX | 89.55 | N/A | N/A |
Columbia Global Technology Growth A | |||
HLHIX | 26.98 | N/A | N/A |
Virtus KAR Health Sciences Inst | |||
RNTTX | 47.47 | -0.05 | -0.11% |
Russell Inv International Devd Mkts M |